HORMONAL INTRAUTERINE SYSTEM: ISSUES OF ITS ACCEPTABILITY AND SAFETY


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper considers current criteria for the acceptability and safety of using the Mirena hormonal intrauterine system depending on the woman’s health status or disease, by analyzing clinical and epidemiological studies in this area.

Full Text

Restricted Access

About the authors

E. V IVANOVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: elena_999@mail.ru

R. A SASUNOVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

A. B LETUNOVSKAYA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

V. N PRILEPSKAYA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

E. A MEZHEVITINOVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

A. V TAGIYEVA

Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

References

  1. Вихляева Е.М., Николаева Е.И. Основные детерминанты репродуктивного поведения женщин: роды и индуцированный аборт // Планирование семьи. - 2001. -№ 1. - С. 15-18.
  2. Кукес В.Г., Сычев Д.А., Бруслик Т. и др. Изучение транспортеров лекарственных средств как новая возможность персонализации фармакотерапии // Врач. - 2007. -№ 5. - С. 2-5.
  3. Медицинские критерии приемлемости применения средств контрацепции. - 3-е изд. - Женева: ВОЗ, 2007.
  4. Медицинские критерии приемлемости применения средств контрацепции.- 4-е изд. - Женева: ВОЗ, 2009.
  5. Прилепская В. Н., Острейкова Л.И. Гормональная внутриматочная левоноргестрел-рилизинг-система «Мирена» // Гинекология. - 2006. - Т. 8, № 2. -С. 38-43.
  6. Руководство по контрацепции / Под ред. В.Н. Прилепской. - М.: МЕДпресс-информ, 2006.
  7. Савельева И.С. Медикаментозный аборт // Вопр. гин., акуш. и перинатол. - 2005. - Т. 4, № 2. - С. 1-4.
  8. Backman T., Huhtala S., Luoto R. et al. Advance information improves user satisfaction with the levonorgestrel intrauterine system // Obstet. and Gynecol. - 2002. - Vol. 99, № 4. -P. 608-613.
  9. Gardner F.J., Konje J.C., Abrams K.R. Endometrial protection from tamoxifen-stimulated changes by a levonorgestrel-releasing intrauterine system: a randomised controlled trial // Lancet. — 2000. — Vol. 356, № 9243. — P. 1711—1717.
  10. Grigorieva V.,Chen-Mok M., Tarasova M., Mikhailov A. Use of levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas // Fertil. and Steril. — 2003. — Vol. 79, № 5. — P. 1194—1198.
  11. Hurskainen R., Teperi J., Rissanen P. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up // J.A.M.A. — 2004. — Vol. 291, № 12. — P. 1456—1463.
  12. Jensen J.T. Contraceptive and therapeutic effects of the levonorgestrel intrauterine system: An overview // Obstet. Gynecol. Surv. — 2005. — Vol. 60, № 9. — P. 604—612.
  13. Kingman C.E., Kadir R.A., Lee C.A., Economides D.L. The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders // Br. J Obstet.Gynaecol. — 2004. — Vol. 111, № 12. — P. 1425—1428.
  14. Pakarinen P., Luukkainen T. Five years’ experience with a small intracervical/intrauterine levonorgestrel-releasing device // Contraception. — 2005. — Vol. 72, № 5. — P. 342—345.
  15. Pakarinen P., Toivonen J., Luukkainen T. Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years’ follow-up // Contraception. — 2003. — Vol. 68, № 1. — P. 31—34.
  16. Rauramo I., Elo L., Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection // Obstet. and Gynecol. — 2004. — Vol. 104, № 6. — P. 1314—1321.
  17. Say R., Mansour D. Contraceptive choice for young people // J. Fam. Plann. Reprod. Hlth Care. — 2009. — Vol. 35, № 2. — P. 81—85.
  18. Templeman C.L., Cook V., Goldsmith L.J. et al. Postpartum contraceptive use among adolescent mothers // Obstet. and Gynecol. — 2000. — Vol. 95, № 5. — P. 770—776.
  19. Van Wouwe J.P., Lanting C.I., van Dommelen P. et al. Breastfeeding duration related to practised contraception in the Netherlands // Acta Paediatr. — 2009. — Vol. 98, № 1. — P. 86—90.
  20. Xuan B.T., Wiebren A.A., Tjalma M.D. Use of the levonorgestrel-releasing intrauterine system in breast cancer patients // Fertil. and Steril. — 2008. — Vol. 90, № 1. — P. 17—22.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies